HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Natural Alternatives International First To Clear NPA's, Retailers' Safety, Compliance Standards

Executive Summary

Contract manufacturer showed compliance with Supplement Safety & Compliance Initiative standards to globally harmonize benchmarks for natul products. Retailers including Amazon and Walmart acknowledge SSCI as benchmarks companies must meet in order to sell products on their platforms.

You may also be interested in...

Natural Alternatives Expands Powder Production With $17.5M Facility Deal

Contract manufacturer Natural Alternatives International purchased $17.5m manufacturing and warehouse facility to provide high-speed powder production capabilities and more aggressively compete in powder supplement space.

ED-Spiked Supplements Sold On Amazon Fill US FDA’s Recall Plate

Announcements for seven adulterated male sexual enhancement products were published across the work week, concluding with NANA Collection LLC’s products branded PremierZen Platinum 5000, found with undisclosed tadalafil, and Triple SupremeZen 3500, found to contain tadalafil and sildenafil, on 2 April.

Health, Beauty And Wellness News: SIDI Protocol, Synthetic Labeling Survey, Recalls, Product Launches

Prebiotic aloe in a Veralixir shot; Carpe targets excessive sweating; Young Living offers subscriptions; Berry Sleepy puts $2.8m behind marketing; Jigsaw supports children's Mineral Power program; Trust Transparency survey on synthetic ingredient labeling; and Beaumont Bio homeopathics recalled.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts